Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review

Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review

Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of allergy and clinical immunology. Global 2024-11, Vol.3 (4), p.100323, Article 100323
Hauptverfasser: Tsunoda, Misuzu, Adachi, Takeya, Nakajima, Yuuri, Yatomi, Yoshihiro, Shimizu, Tomoko, Nakasute, Katsuki
Format: Artikel
Sprache:eng
Schlagworte:
atopic disease
Dupilumab
psoriasis
psoriatic arthritis
upadacitinib
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.
ISSN:2772-8293
2772-8293
DOI:10.1016/j.jacig.2024.100323